Covid UK: GlaxoSmithKline to ‘fill and finish’ 60million doses of Novavax vaccine

Boris Johnson tonight revealed GlaxoSmithKline will support the manufacturing of up to 60million doses of the Novavax coronavirus vaccine in the UK. No10’s vaccines taskforce has signed a deal with British drugs giant GSK to ‘fill and finish’ supplies of the American jab at its factory in Durham starting from May. Mr Johnson said the move … Read more

UK signs deal with GlaxoSmithKline to ‘fill and finish’ 60million doses of Novavax’s Covid vaccine

We don’t need EU anyway: Boris Johnson reveals UK has signed deal with drugs giant GlaxoSmithKline to ‘fill and finish’ 60million doses of Novavax’s Covid vaccine in Durham GSK will support manufacturing of the American-made vaccine starting in May Novavax jab shown to be 86% effective against Kent variant of Covid in trials By Connor … Read more

Matt Hancock hails Novavax jab’s 86.3% effectiveness against Kent Covid strain

Matt Hancock last night hailed the Novavax vaccination’s 86.3 per cent effectiveness against the Kent strain of Covid-19. The Health Secretary confirmed the UK has 60 million doses of the jab, developed in Gaithersburg, Maryland, on order ahead of its approval by the medicines regulator. He said: ‘Really encouraging results from Novavax tonight on its efficacy against variants.  ‘We’ve … Read more

Covid: EU still negotiating for Novavax vaccine UK bought months ago

The war between the EU and AstraZeneca deepened on Friday as Brussels published a redacted version of the confidential vaccines contract it signed with the drug-maker. The EU hopes publishing the contract will force AstraZeneca to supply it with millions of jabs manufactured at UK factories to make up for shortfalls at a Belgian plant … Read more

Novavax will submit results to UK regulator ‘within two weeks’, clinical trial chief says

The Novavax coronavirus vaccine could submit its results to the UK regulator within two weeks, says the clinical trial chief, with supplies set to be available this summer. Early results show the jab is 89.3 effective against the virus including the Kent strain in a glimmer of hope the UK could add a fourth jab … Read more

EU vaccine: Europe still negotiating for Novavax jabs that UK bought five months ago

The EU’s vaccine shambles descended further into chaos today as it emerged the bloc has not yet signed a deal to buy British-made Novavax jabs which passed phase III trials yesterday with a 90% success rate.  Ministers from the EU commission only completed ‘exploratory’ talks to buy Novavax, which is being made in a Tesside … Read more

UK vaccine chief ‘broke Dry January’ after British Novavax jab passed

The UK’s vaccine chief today revealed she cracked open the wine and ‘broke dry January’ last night after learning another jab set be made in Britain was proved to beat Covid-19.  Kate Bingham, who stepped down as chairwoman of the UK Vaccine Taskforce on January 1, also revealed that she was one of the people who took … Read more

Top bosses at drugs firm Novavax pocket £34m windfall as Covid-19 vaccine enters late-stage trials

Top bosses at drugs company Novavax pocket £34m windfall as Covid-19 vaccine enters late-stage trials By City & Finance Reporter for the Daily Mail Published: 23:39 GMT, 12 January 2021 | Updated: 23:39 GMT, 12 January 2021 Novavax has a potential Covid-19 vaccine and it has entered late-stage trials Top bosses at a drugs company … Read more

Novavax delays US trials for COVID vaccine and says late-stage study will begin ‘in coming weeks’

Novavax delays US trials for its coronavirus vaccine AGAIN and says late-stage study will begin ‘in the coming weeks’ as it struggles to scale up production of its jab Novovax delayed the start of its late-stage US trials for the second time after initially declaring a start date in October and then November The company said … Read more